Struma Ovarii with Pseudo-Meigs Syndrome and Increased CA-125 Levels: Case Report
DOI:
https://doi.org/10.32635/2176-9745.RBC.2023v69n4.4177Keywords:
struma ovarii, ovarian neoplasms, pseudo-Meigs syndrome, CA-125 antigenAbstract
Struma ovarii is a rare type of ovarian tumor composed of more than 50% of thyroid tissue. It represents only 1% of solid ovarian tumors and 3% of dermoid subtypes, with the majority of cases following a benign course. It typically affects women between the third and fifth decades of life and often remains asymptomatic or presents with nonspecific signs. pseudo-Meigs syndrome, characterized by ascites and pleural effusion, may be present, complicating the diagnosis. Case report: A 43-year-old woman presented with abdominal discomfort, pelvic pain, and chronic dyspnea. A CT scan identified a solid-cystic pelvic mass, moderate ascites, and right-sided pleural effusion. Magnetic resonance imaging (MRI) confirmed the findings, raising suspicion of malignant ovarian tumor. The serum tumor marker CA-125 was elevated. The patient underwent exploratory laparotomy, resulting in bilateral salpingo-oophorectomy. Histopathological analysis of the specimen confirmed the diagnosis of struma ovarii in the left ovary and mature cystic teratoma in the right ovary. Conclusion: Elevated CA-125 levels can be found in cases of struma ovarii, posing a differential diagnosis challenge with malignant ovarian neoplasms, especially when associated with pseudo-Meigs syndrome. Therefore, although rare, it should be considered as a possibility during clinical investigation of ovarian masses with atypical presentations. Imaging studies can assist, but confirmation is established through microscopic analysis. Treatment involves simple surgical resection, and symptom disappearance follows, with favorable prognosis.
Downloads
References
Zamani F, Abdolrazaghnejad A, Ameli F, et al. Struma ovarii: a case report and review the literature. Int J Surg Case Rep. 2022;96:107318. doi: https://doi.org/10.1016/j.ijscr.2022.107318 DOI: https://doi.org/10.1016/j.ijscr.2022.107318
World Health Organization. WHO Classification of Tumours editorial board. female genital tumours. 5 ed. Lyon: International Agency for Research on Cancer; 2020.
Weinberger V, Kadlecova J, Minář L, et al. Struma ovarii - ultrasound features of a rare tumor mimicking ovarian cancer. Med Ultrason. 2018;20(3):355-61. doi: https://doi.org/10.11152/mu-1526 DOI: https://doi.org/10.11152/mu-1526
Taelman V, Boer M, Taelman P. Metastatic malignant struma ovarii: a case report and review of the literature on the management of malignant struma ovarii. Acta Clin Belg. 2022;77(3):721-5. doi: https://doi.org/10.1080/17843286.2021.1944583 DOI: https://doi.org/10.1080/17843286.2021.1944583
Addley S, Mihai R, Alazzam M, et al. Malignant struma ovarii: surgical, histopathological and survival outcomes for thyroid-type carcinoma of struma ovarii with recommendations for standardising multi-modal management. Arch Gynecol Obstet. 2021;303:863-70. doi: https://doi.org/10.1007/s00404-021-05969-0 DOI: https://doi.org/10.1007/s00404-021-05969-0
Wang S, He X, Yang H, et al. Struma ovarii associated with ascites and elevated CA125: two case reports and review of the Literature. Int J Women's Health. 2022;(14):1291-6. doi: https://doi.org/10.2147/IJWH.S349808 DOI: https://doi.org/10.2147/IJWH.S379128
Yadav S, Tomar R, Verma N, et al. Struma Ovarii with Pseudo-Meigs' Syndrome and raised cancer antigen-125 levels masquerading as an ovarian carcinoma: case report and literature review. Sultan Qaboos Univ Med J. 2017;17(2):e229-33. doi: https://doi.org/10.18295/squmj.2016.17.02.017 DOI: https://doi.org/10.18295/squmj.2016.17.02.017
Koehler VF, Keller P, Waldmann E, et al. An unusual case of struma ovarii. Endocrinol Diabetes Metab Case Rep. 2021;2021(1):1-4. doi: https://doi.org/10.1530/EDM-20-0142 DOI: https://doi.org/10.1530/EDM-20-0142
Leuștean L, Ungureanu MC, Preda C, et al. Management of malignant struma ovarii: is aggressive therapy justified? Case report and literature review. Thyroid Res. 2022;15(1):14. doi: https://doi.org/10.1186/s13044-022-00132-6 DOI: https://doi.org/10.1186/s13044-022-00132-6
Sohrabi C, Mathew G, Maria N, et al. The SCARE 2023 guideline: updating consensus Surgical CAse REport (SCARE) guidelines. Int J Surg. 2023;109(5):1136-40. doi: https://doi.org/10.1097/JS9.0000000000000373 DOI: https://doi.org/10.1097/JS9.0000000000000373
Conselho Nacional de Saúde (BR). Resolução n° 466, de 12 de dezembro de 2012. Aprova as diretrizes e normas regulamentadoras de pesquisas envolvendo seres humanos. Diário Oficial da União, Brasília, DF. 2013 jun 13; Seção I:59.
Liu Y, Tang GY, Liu L, et al. Giant struma ovarii with pseudo-Meigs'syndrome and raised cancer antigen-125 levels: A case report. World J Clin Cases. 2022;10(30):11155-61. doi: https://doi.org/10.12998/wjcc.v10.i30.11155 DOI: https://doi.org/10.12998/wjcc.v10.i30.11155
Morrissey K, Winkel C, Hild S, et al. Struma ovarii coincident with Hashimoto's thyroiditis: an unusual cause of hyperthyroidism. Fertil Steril. 2007;88(2):497.e15-7. doi: https://doi.org/10.1016/j.fertnstert.2006.11.095 DOI: https://doi.org/10.1016/j.fertnstert.2006.11.095
Ayhan S, Kilic F, Ersak B, et al. Malignant struma ovarii: from case to analysis. J Obstet Gynecol Res. 2021;47(9):3339-51. doi: https://doi.org/10.1111/jog.14845 DOI: https://doi.org/10.1111/jog.14902
Published
How to Cite
Issue
Section
License
Os direitos morais e intelectuais dos artigos pertencem aos respectivos autores, que concedem à RBC o direito de publicação.
This work is licensed under a Creative Commons Attribution 4.0 International License.